Acquired stenosis of external ear canal

H8_STENOEXTCAN

auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H61.3 Hospital discharge: ICD-9 — 3805 Cause of death: ICD-10 — H61.3 Cause of death: ICD-9 — 3805 2 out of 7 registries used, show all original rules.	323
4. Check minimum number of events None	323
5. Include endpoints None	323
6. Filter based on genotype QC (FinnGen only)	323

Control definitions (FinnGen only)

Control exclude: H8_EXTERNAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H61
Name in latin: Stenosis meatus acustici externi acquisita

NAME	H8_STENOEXTCAN
CONTROL_EXCLUDE	H8_EXTERNAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H613
HD_ICD_9	3805
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H613
COD_ICD_9	3805
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acquired stenosis of external ear canal based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1833	644	1188
Only index persons	1756	613	1143
Unadjusted period prevalence (%)
Whole population	0.03	0.02	0.03
Only index persons	0.04	0.02	0.04
Median age at first event (years)
Whole population	57.68	56.60	58.25
Only index persons	57.63	56.73	58.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	323	100	223
Unadjusted period prevalence (%)	0.08	0.03	0.10
Median age at first event (years)	60.36	55.17	62.69

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
282: Matched controls
2817

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H61.3

ICD-10 Finland

Acquired stenosis of external ear canal

4503599627370496.0

323.0

274

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

1148.3

143.2

128

H61.8

ICD-10 Finland

Other specified disorders of external ear

397.2

64.2

UDC00

NOMESCO Finland

Ear microscopy

14.2

52.2

DFF00

NOMESCO Finland

Pure tone audiometry

10.7

45.5

129

Z01.1

ICD-10 Finland

Examination of ears and hearing

7.3

35.2

187

H60.8

ICD-10 Finland

Other otitis externa

43.6

31.1

H60.3

ICD-10 Finland

Other infective otitis externa

56.7

30.1

H60.9

ICD-10 Finland

Otitis externa, unspecified

12.8

29.6

DBB00

NOMESCO Finland

Excision of lesion of external auditory canal

+∞

25.4

H71

ICD-10 Finland

Cholesteatoma of middle ear

31.6

20.0

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

22.0

19.5

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

3.8

16.3

257

DC1AD

NOMESCO Finland

Temporalbone CT

35.7

16.0

H61.2

ICD-10 Finland

Impacted cerumen

7.7

14.6

H60

ICD-10 Finland

Otitis externa

8.8

13.7

H65.3

ICD-10 Finland

Chronic mucoid otitis media

17.3

13.7

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

14.2

12.1

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

62.4

10.7

ZXE00

NOMESCO Finland

One hour or less

2.4

10.6

131

754

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

10.0

122

693

TDA90

NOMESCO Finland

Removal wax from ear

18.3

9.5

DBD30

NOMESCO Finland

Correction of atresia of external auditory canal

+∞

9.4

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

6.7

9.3

Z97.4

ICD-10 Finland

Presence of external hearing-aid

6.0

9.0

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

51.6

8.7

R5120

NOMESCO Finland

Preparation of an aid

7.5

8.4

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

11.2

8.4

3805A

ICD-9 Finland

Disorders of external ear, Acquired stenosis of external ear canal

+∞

8.4

4111

FHL

Ear canal extension

+∞

8.4

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

6.4

8.3

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

8.3

506

H66.0

ICD-10 Finland

Acute suppurative otitis media

4.5

8.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

7.8

350

S03CA01

ATC

dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)

7.5

7.6

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

7.6

116

707

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

+∞

7.3

38700

ICD-8 Finland

Other disease of ear and mastoid process, Cholesteatoma of ear

+∞

7.3

DFF15

NOMESCO Finland

Speech audiometry

4.9

7.1

ZXA10

NOMESCO Finland

Bilateral

2.4

7.0

287

WX002

NOMESCO Finland

Sedation and analgesia

2.3

6.9

338

H60.4

ICD-10 Finland

Cholesteatoma of external ear

41.0

6.8

J01DB01

ATC

cefalexin; oral

2.2

6.7

233

1922

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

6.5

6.6

H01

ICPC

Ear pain/earache

3.4

6.6

D07AB02

ATC

hydrocortisone butyrate; topical

2.1

6.5

464

H66.9

ICD-10 Finland

Otitis media, unspecified

4.7

6.3

Q16.1

ICD-10 Finland

Congenital absence, atresia and stricture of auditory canal (external)

+∞

6.3

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

4.9

6.2

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

323

2.87

13.43

2.3

1.8

—

(3000494) Fungus identified in Specimen by Culture

331

2.29

7.69

1.7

1.4

—

(3042936) Bacteria identified in Isolate by Culture

430

1.94

5.44

2.0

2.1

—

(3044889) 12 lead EKG panel

234

1942

1.74

4.72

3.9

4.0

—

(42870588) Differential panel, method unspecified - Blood

123

902

1.59

3.80

6.4

5.9

—

(3019150) Specific gravity of Urine by Refractometry

589

0.49

3.63

3.0

3.9

kg/l

1.0

—

(40768443) Skin Pathology biopsy report

105

2.39

3.62

1.1

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

288

2615

1.94

3.43

4.6

4.7

mmol/l

6.0

6.1

0.52

261

2393

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

307

2862

2.47

3.27

11.2

10.9

u/l

25.9

27.9

1.72

298

2781

(3021589) Normoblasts [#/volume] in Blood

152

1199

1.51

3.25

9.9

9.8

e9/l

0.0

0.62

120

989

(3002256) Pathology report gross observation

328

1.74

3.12

1.7

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

285

1.76

2.97

3.2

3.5

—

(3006504) Eosinophils/100 leukocytes in Blood

156

1256

1.47

2.92

6.2

5.8

2.9

0.04

147

1190

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

294

2716

1.92

2.89

4.7

5.1

mmol/l

2.7

0.14

268

2505

(3002385) Erythrocyte distribution width [Ratio]

252

2242

1.56

2.80

17.6

18.3

13.7

13.8

0.31

245

2204

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

277

2523

1.69

2.76

15.9

13.8

ml/min/173m2

80.4

0.01

236

2112

(3019069) Monocytes/100 leukocytes in Blood

156

1267

1.45

2.73

6.5

6.1

9.0

8.9

0.24

148

1206

(3022096) Basophils/100 leukocytes in Blood

151

1222

1.44

2.68

6.2

5.8

0.7

0.6

1.17

143

1159

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2.86

2.67

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

158

1291

1.44

2.66

6.3

5.9

27.1

26.7

0.15

149

1219

(3018418) pH of Serum or Plasma

104

786

1.48

2.63

3.9

4.2

7.4

0.31

155

(3019198) Lymphocytes [#/volume] in Blood

165

1366

1.43

2.55

5.7

5.9

e9/l

2.1

1.8

0.50

151

1219

(3001604) Monocytes [#/volume] in Blood

162

1338

1.42

2.53

5.8

e9/l

0.6

0.41

143

1167

(3009542) Hematocrit [Volume Fraction] of Blood

268

2437

1.59

2.51

16.1

15.8

41.0

40.3

0.88

198

1728

(3006315) Basophils [#/volume] in Blood

162

1340

1.42

2.50

5.8

5.9

e9/l

0.0

0.43

143

1179

(3019550) Sodium [Moles/volume] in Serum or Plasma

298

2787

1.89

2.49

17.7

17.4

mmol/l

139.7

139.6

0.18

292

2734

(3018010) Neutrophils/100 leukocytes in Blood

155

1274

1.42

2.47

5.9

5.7

57.2

57.6

0.20

148

1211

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

218

1905

1.44

2.45

3.2

3.6

pmol/l

14.6

14.9

1.62

201

1704

(3007461) Platelets [#/volume] in Blood

312

2970

2.48

2.41

22.7

21.9

e9/l

241.9

240.8

0.11

303

2905

(3013115) Eosinophils [#/volume] in Blood

165

1375

1.41

2.41

5.9

6.1

e9/l

0.2

0.24

147

1230

(3035941) MCH [Entitic mass]

312

2972

2.46

2.37

22.6

21.8

30.4

30.5

0.25

307

2940

(3024731) MCV [Entitic volume]

312

2972

2.46

2.37

22.7

21.8

91.2

0.00

307

2940

(3026361) Erythrocytes [#/volume] in Blood

312

2973

2.45

2.35

22.8

21.9

e12/l

4.5

0.02

301

2897

(3013650) Neutrophils [#/volume] in Blood by Automated count

184

1567

1.40

2.34

7.9

9.7

e9/l

4.1

4.2

0.33

158

1386

(3010813) Leukocytes [#/volume] in Blood

312

2974

2.44

2.33

22.8

21.9

e9/l

6.7

0.06

300

2899

(3000850) Epithelial cells [#/volume] in Urine

569

1.49

2.33

2.1

2.5

e6/l

2.8

4.1

1.05

505

(3000963) Hemoglobin [Mass/volume] in Blood

312

2975

2.43

2.31

22.9

22.0

g/l

137.7

137.6

0.06

307

2939

(3023103) Potassium [Moles/volume] in Serum or Plasma

298

2798

1.84

2.29

17.9

17.5

mmol/l

4.0

0.45

292

2747

(40761535) Cells panel - Urine sediment

212

0.41

2.29

2.4

3.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.95

2.26

1.0

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

3.95

2.26

1.7

2.3

13.2

13.3

—

(3000492) Spirometry study

260

1.66

2.23

1.8

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

287

2677

1.65

2.13

4.5

4.6

mmol/l

4.6

4.5

0.70

265

2484

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

259

2364

1.48

2.11

4.5

4.3

mu/l

2.0

1.9

0.14

233

2139

(3018095) Leukocytes [#/volume] in Urine

118

953

1.38

1.98

3.2

3.6

e6/l

49.6

57.3

0.12

703

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

749

1.40

1.98

1.6

1.7

mmol/l

1.4

0.19

627

(3042631) Mycobacterium sp identified in Specimen

2.61

1.94

3.5

3.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

180

1560

1.35

1.89

2.6

2.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

221

1977

1.37

1.89

3.8

4.1

mm/h

11.7

0.01

204

1829

(3015377) Calcium [Moles/volume] in Serum or Plasma

106

847

1.37

1.89

4.0

3.6

mmol/l

2.4

2.3

1.10

750

(40768804) Tissue Pathology biopsy report

124

1016

1.36

1.89

2.9

2.1

—

(40761511) CBC panel - Blood by Automated count

296

2803

1.67

1.79

14.7

14.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2.03

1.78

1.3

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

127

1053

1.34

1.76

2.7

ug/l

139.5

156.8

0.41

113

965

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

2.18

1.74

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

3.89

1.72

1.2

1.0

nmol/l

162.2

152.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

406

1.46

1.72

1.3

iu/ml

17.8

33.8

1.44

132

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

221

1.60

1.71

3.6

4.1

mmol/l

1.2

0.50

198

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

284

2671

1.52

1.69

15.6

15.0

mg/l

28.0

25.4

0.54

232

2146

(3013826) Glucose [Moles/volume] in Serum or Plasma

186

1637

1.32

1.68

4.0

5.0

mmol/l

6.7

6.8

0.04

175

1536

(4035726)

232

1.57

1.63

1.8

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.73

1.59

1.3

1.4

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

3.04

1.59

1.7

1.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

243

1.54

1.55

2.1

2.5

u/l

35.9

227.8

0.49

209

(3037522) Nuclear Ab [Titer] in Serum

328

1.47

1.54

1.3

1.4

titre

354.3

541.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

277

1.51

1.54

1.7

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

311

1.48

1.54

2.4

2.2

nmol/l

13.5

13.8

0.05

280

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

282

2659

1.48

1.54

4.2

4.5

mmol/l

1.4

0.07

258

2449

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

270

2534

1.40

1.43

5.5

6.1

mmol/mol

39.5

40.4

1.01

246

2367

(40761536) Microorganisms panel - Urine sediment

224

1.53

1.40

4.4

3.3

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.64

1.37

1.2

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

229

2103

1.31

1.37

7.8

8.1

u/l

78.5

79.1

0.08

206

1978

(3035320) C reactive protein [Mass/volume] in Body fluid

2.97

1.36

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.82

1.35

2.3

1.7

—

(3045414) Leukocytes [Presence] in Urine

113

1.72

1.35

1.1

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

571

1.34

1.32

1.3

1.8

mg/l

1.0

1.4

1.06

453

(3000093) Morphology [Interpretation] in Blood Narrative

2.53

1.31

1.3

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

2.12

1.29

5.3

3.9

49.6

58.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

643

1.30

1.21

2.1

mg/l

2.7

3.0

0.81

551

(40758558) Short blood count panel - Blood

671

1.30

1.20

5.7

7.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.33

1.19

1.2

1.4

—

(4268621)

0.00

1.16

0.0

2.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

1.16

0.0

1.2

—

(4062490)

2.36

1.13

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

100

846

1.26

1.13

3.0

3.1

e6/l

28.8

127.2

0.69

659

(36304419) Bacteria [Presence] in Urine

743

1.27

1.12

3.1

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1041

0.79

1.12

3.3

3.6

—

(4094501)

1.76

1.04

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

163

1466

1.23

1.04

5.1

4.7

ug/l

2.1

2.2

0.16

144

1317

(3026782) Osmolality of Urine

536

1.29

1.03

2.5

2.8

mosm/kgh2o

588.4

579.6

0.11

465

(3030905) Polymorphonuclear cells [#/volume] in Blood

1.94

1.03

3.7

3.1

e9/l

3.0

4.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.65

1.02

2.1

1.9

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

317

0.67

1.01

4.8

8.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

101

867

1.24

0.99

3.0

2.9

ug/l

0.8

0.7

0.17

558

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

2.19

0.98

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2.19

0.98

1.0

1.7

g/l

1.1

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.98

0.0

1.2

—

2.3

—

(3000034) Microalbumin [Mass/volume] in Urine

0.00

0.98

0.0

3.7

—

21.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1.88

0.97

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

1.82

0.97

1.1

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

504

1.28

0.96

3.6

3.9

ng/l

171.1

326.9

0.62

415

(3014111) Lactate [Moles/volume] in Serum or Plasma

244

1.39

0.95

5.1

6.9

mmol/l

1.5

1.3

0.35

231

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

135

1200

1.21

0.95

5.0

6.0

mmol/l

1.2

0.09

128

1094

(3012516) Albumin [Mass/volume] in Urine

843

1.23

0.94

3.1

3.2

mg/l

55.3

256.8

1.01

569

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

146

1308

1.21

0.94

6.3

7.1

mmol/l

1.2

0.51

115

1115

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

387

1.31

0.94

1.3

u/ml

6.3

10.8

0.34

153

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

645

1.25

0.94

2.5

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.74

0.94

1.5

1.6

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

143

1280

1.21

0.93

3.9

4.2

—

(3009508) Creatinine [Moles/volume] in Urine

102

883

1.23

0.92

2.9

3.0

mmol/l

8.7

8.3

0.36

729

(3026389) Candida sp identified in Specimen by Organism specific culture

2.16

0.92

2.3

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

593

1.25

0.89

3.9

4.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.64

0.89

1.7

g/l

37.7

0.01

(3000991) Gas panel - Venous blood

222

1.39

0.87

5.6

8.4

—

(3025941) Bacteria identified in Stool by Culture

145

1.48

0.87

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

269

2572

1.27

0.87

4.0

4.1

mmol/l

1.4

1.3

1.23

248

2358

(1002224) Polysomnography panel

112

1.55

0.86

1.3

1.1

—

(40768800) Prostate Pathology biopsy report

1.62

0.86

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.95

0.85

1.3

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.78

0.84

1.1

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

113

997

1.21

0.84

2.2

2.3

nmol/l

73.1

74.3

0.16

887

(3052851) Hemolysis interference index of Serum or Plasma

1.63

0.82

3.2

3.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

216

1.38

0.82

1.3

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

113

1000

1.20

0.81

3.0

3.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

196

1823

1.19

0.80

2.8

3.4

u/l

40.2

54.2

3.70

174

1713

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.83

0.79

3.2

3.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

149

1.44

0.78

6.4

9.4

mmol/l

24.7

0.02

139

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

121

1085

1.18

0.74

1.9

pmol/l

90.8

95.2

0.43

600

(3030467) Casts [#/volume] in Urine by Automated count

768

1.20

0.73

3.2

3.0

e6/l

0.2

0.5

1.36

583

(3005570) Glucose [Moles/volume] in Urine

2.02

0.73

1.8

2.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

159

1462

1.17

0.72

6.0

7.1

umol/l

12.0

0.02

151

1394

(3014051) Protein [Presence] in Urine by Test strip

1.60

0.71

1.1

2.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

755

1.19

0.67

2.3

2.8

umol/l

5856.4

5410.2

0.03

657

(36660697) Celiac disease serology panel - Serum

189

1.35

0.67

1.1

1.2

—

(3019060) Gas panel - Arterial blood

201

0.68

0.66

2.6

5.1

—

(3045788) Cell count panel - Pleural fluid

1.80

0.66

2.4

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

100

892

1.18

0.65

3.9

3.8

mg/mmol

9.3

8.6

0.07

593

(3009445) Proteinase 3 Ab [Units/volume] in Serum

129

1.42

0.65

1.3

1.2

—

15.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

113

1.44

0.62

2.1

1.9

ug/l

416.7

681.8

0.27

105

(3026008) Bacteria identified in Urine by Culture

717

0.83

0.62

3.6

3.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.68

0.61

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

1.68

0.61

4.4

3.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

157

1.36

0.61

4.9

8.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

0.60

0.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.60

0.0

1.3

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.60

0.0

1.3

—

(40768797) Stomach Pathology biopsy report

356

1.24

0.60

1.3

—

(40768441) Liver Pathology biopsy report

0.00

0.60

0.0

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

849

1.17

0.60

3.0

3.1

ng/l

1408.0

1339.9

0.06

728

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.59

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.59

0.0

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.59

0.0

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.59

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.59

0.0

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

0.00

0.59

0.0

1.8

—

2.6

—

(3022145) Colonoscopy Study observation

302

1.25

0.59

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

184

0.69

0.58

1.8

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

329

0.77

0.58

1.3

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.45

0.57

1.7

1.9

g/l

8.5

10.4

1.30

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.68

0.57

4.7

2.1

32.3

34.0

—

(4034850)

0.55

0.56

4.2

11.3

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

125

0.63

0.55

4.1

3.5

u/ml

29.9

400.4

—

102

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

444

1.20

0.55

2.0

1.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

1.41

0.54

1.7

1.9

—

(3037756) Immunofixation for Serum or Plasma

1.46

0.53

1.2

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

179

0.71

0.51

6.7

3.5

g/l

123.2

128.7

0.38

174

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

476

1.19

0.51

2.6

2.7

e6/l

0.6

1.0

0.68

279

(3007164) IgA [Mass/volume] in Serum or Plasma

515

1.18

0.50

1.5

1.4

g/l

2.5

2.7

0.41

319

(3037121) Protein [Mass/volume] in Urine

1.45

0.50

2.8

3.3

g/l

0.1

0.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

450

1.19

0.49

2.7

2.9

e6/l

1.2

1.6

0.21

257

(4010399)

201

1.26

0.46

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

183

1.28

0.46

1.8

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

719

0.86

0.46

3.6

3.8

estimate

0.0

0.68

244

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1.44

0.46

1.0

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1.44

0.46

1.0

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.44

0.46

1.5

1.7

—

(3019225) pH of Specimen

241

0.78

0.45

2.9

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

868

1.13

0.44

2.5

2.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1.38

0.44

1.6

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

128

0.69

0.44

2.1

2.2

ug/l

1.4

3.8

—

115

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

128

1192

1.12

0.44

4.4

4.2

21.8

21.1

0.17

551

(3004716) Salmonella sp identified in Stool by Organism specific culture

131

0.68

0.44

1.1

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

113

1.34

0.43

2.5

2.9

—

(3045142) Bone marrow Pathology biopsy report

1.62

0.43

1.4

1.2

—

(1616796) Gas panel - Central venous blood

1.41

0.42

3.6

3.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.57

0.42

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

1.57

0.42

2.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.57

0.42

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1.57

0.42

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.37

0.42

1.7

1.8

—

(3032080) INR in Blood by Coagulation assay

126

1175

1.12

0.42

9.5

9.7

inr

1.3

1.2

0.43

341

(3014271) Vancomycin [Susceptibility]

0.00

0.41

0.0

2.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

2.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.00

0.41

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.41

0.0

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

4.7

—

(3015183) Erythrocyte sedimentation rate

0.00

0.41

0.0

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.2

—

7.4

—

(3024263) Appearance of Synovial fluid

0.00

0.41

0.0

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1.38

0.40

1.2

1.3

—

3.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

151

1.27

0.39

2.1

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.39

0.0

2.5

—

103.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.39

0.0

3.3

—

(3025159) Blasts/100 leukocytes in Blood

197

1.24

0.39

4.0

3.9

0.0

0.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

376

1.17

0.37

3.1

2.4

20.8

23.1

0.68

320

(40768806) Pleura Pathology biopsy report

1.36

0.37

2.8

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

298

0.83

0.36

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

339

1.17

0.36

2.3

3.4

umol/l

12.8

9.5

0.22

302

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.28

0.36

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

264

1.19

0.36

1.9

2.5

g/l

0.2

0.60

242

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1.44

0.35

1.0

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

483

1.14

0.35

1.9

1.7

nmol/l

1178.2

1193.3

0.04

373

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1.38

0.35

1.1

2.0

mg/l

8.3

11.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

200

1.22

0.35

4.2

3.6

0.6

0.4

—

(40768793) Breast Pathology biopsy report

1.37

0.34

1.0

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

823

1.11

0.34

2.4

2.1

u/l

256.3

278.7

0.08

780

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

182

1.22

0.34

2.5

3.0

mmol/l

3.0

1.6

0.79

134

(3022217) INR in Platelet poor plasma by Coagulation assay

358

0.85

0.33

30.5

23.6

inr

1.2

1.3

—

(3013512) EKG study

818

1.10

0.31

3.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

574

0.89

0.30

1.6

1.8

pmol/l

405.9

23809958.2

0.50

483

(3041096) Erythrocytes [Presence] in Urine by Automated

749

0.90

0.30

3.1

3.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

217

0.82

0.30

1.9

2.6

ml/min/173m2

52.7

63.4

—

(3021901) Oxygen saturation in Capillary blood

1.28

0.30

2.7

2.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.26

0.29

1.3

1.1

—

(3049717) Cytology report of Urine Cyto stain

129

0.77

0.28

1.8

3.0

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

103

1.27

0.28

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1.28

0.28

1.1

1.3

—

2.7

—

(3020891) Body temperature

117

0.76

0.28

2.2

4.1

—

(3009261) Glucose [Presence] in Urine by Test strip

126

1323

0.92

0.27

3.1

3.5

estimate

0.0

0.00

241

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

122

1.24

0.27

2.1

4.6

mmol/l

25.0

24.4

0.74

112

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.31

0.26

1.3

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.68

0.26

1.6

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

151

1.20

0.25

1.1

1.6

—

(3022313) Gas panel - Capillary blood

151

1.20

0.25

2.7

2.9

—

(3010421) pH of Blood

1.19

0.25

2.7

3.1

7.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

208

1.17

0.24

4.2

3.8

0.1

0.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.17

0.24

1.6

1.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

158

0.82

0.24

1.1

1.2

—

(3023520) Reticulocytes [#/volume] in Blood

247

1.15

0.23

4.2

2.7

e9/l

76.4

68.9

0.42

189

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.32

0.23

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

189

1834

1.07

0.23

4.3

4.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.76

0.23

2.3

1.7

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

547

1.10

0.22

1.2

u/ml

7.5

1.1

—

156

(3023419) Bacteria identified in Sputum by Culture

1.22

0.22

1.8

2.8

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

0.21

0.0

1.4

—

(44806420)

0.00

0.21

0.0

2.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(4198724)

0.00

0.21

0.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.00

0.21

0.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(3021788) Differential panel - Synovial fluid

1.17

0.21

1.0

1.5

—

(3044007) Cell count panel - Peritoneal fluid

0.00

0.21

0.0

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.21

0.0

1.0

—

(3028433) Virus identified in Specimen by Culture

0.00

0.21

0.0

1.2

—

(3008898) HLA-B27 [Presence]

1.26

0.20

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.25

0.20

2.8

2.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.25

0.20

1.3

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

0.00

0.20

0.0

1.6

—

5198.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

144

0.83

0.20

6.4

3.5

mmol/l

24.3

25.0

0.29

138

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1.18

0.19

1.3

1.4

—

89.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.19

0.18

1.0

1.2

—

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.15

0.17

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1.15

0.17

1.7

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1.13

0.17

1.0

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

909

1.06

0.17

2.7

4.0

u/l

29.1

32.8

1.11

866

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

120

1.17

0.16

1.4

2.1

u/l

40.2

38.2

0.17

107

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

235

0.89

0.16

1.6

1.8

—

(3027944) Amphetamines [Presence] in Urine

0.78

0.16

1.0

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

226

1.12

0.15

4.3

3.8

1.0

—

(21494755) Public health laboratory ask at order entry panel

244

0.89

0.15

1.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

192

0.88

0.15

1.2

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

382

1.08

0.15

1.5

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.09

0.15

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

208

1.11

0.14

1.2

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

305

1.09

0.14

2.2

2.3

ug/g

253.7

143.3

0.33

251

(3004588) Protein electrophoresis panel - Serum or Plasma

189

1.12

0.14

2.1

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

458

0.93

0.14

2.1

30.6

29.7

0.49

444

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1.18

0.13

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

121

1175

1.05

0.13

5.6

5.4

g/l

34.7

35.4

0.68

108

1104

(3023368) Bacteria identified in Blood by Culture

810

1.05

0.12

3.9

4.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

143

1.13

0.11

1.9

2.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

367

1.07

0.11

6.4

6.7

mmol/l

104.4

104.0

0.25

356

(3011288) Drugs identified in Urine by Screen method

1.04

0.09

1.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1.11

0.09

1.8

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.09

0.09

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.07

0.08

1.5

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1.05

0.08

1.2

2.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.04

0.08

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.82

0.08

1.2

1.5

—

245.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.82

0.08

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

156

1.09

0.08

1.2

1.4

—

(3021601) Nitrite [Presence] in Urine by Test strip

128

1304

0.97

0.07

4.1

4.7

estimate

0.0

0.00

258

(3016879) Cocaine [Presence] in Urine

0.83

0.07

1.0

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.80

0.07

1.2

1.3

—

(3022621) pH of Urine by Test strip

194

0.92

0.07

2.3

2.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.82

0.07

1.1

1.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.88

0.07

5.6

3.3

—

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

187

1.07

0.06

5.1

4.1

ng/l

132.4

85.3

0.69

173

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

375

0.95

0.06

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

115

1131

1.03

0.06

3.4

3.8

ng/l

23.0

41.7

2.88

835

(3000330) Specific gravity of Urine by Test strip

141

0.92

0.05

1.9

3.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

131

1.07

0.03

1.1

1.2

iu/ml

59.6

178.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

179

0.95

0.03

1.2

1.4

—

(1761868) Lipid panel - Serum or Plasma

1002

0.98

0.03

2.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

909

1.02

0.02

2.8

2.7

u/l

55.1

57.4

0.26

846

(3020630) Protein [Mass/volume] in Serum or Plasma

232

1.04

0.02

2.1

2.8

g/l

65.3

66.2

0.29

215

(3012544) pH of Venous blood

266

0.98

0.00

4.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

119

1.01

0.00

1.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

652

1.00

0.00

1.6

nmol/l

20.7

20.4

0.07

561

(3003694) ABO and Rh group [Type] in Blood

749

1.00

0.00

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

167

1.02

0.00

1.4

2.9

e6/l

0.1

0.2

1.54

161

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

317

1.01

0.00

2.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

325

1.02

0.00

2.0

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

106

1.04

0.00

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

256

1.02

0.00

4.2

4.1

kpa

6.3

5.8

1.36

244

(3011397) Hemoglobin [Presence] in Urine by Test strip

594

0.99

0.00

2.5

3.5

—

(3035350) Ketones [Presence] in Urine by Test strip

129

1295

0.99

0.00

2.9

3.5

estimate

0.0

0.00

251

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

0.0

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.0

8.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.0

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.2

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.0

1.5

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.0

1.4

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

4.7

—

(3024932) HLA-DR beta [Type]

0.00

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.0

1.6

—

(3034426) Prothrombin time (PT)

0.00

0.0

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.88

0.00

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.0

8.9

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

26.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.0

7.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.00

0.00

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

170

1.00

0.00

1.3

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.00

0.00

2.6

3.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

0.0

2.0

—

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

0.93

0.00

1.0

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.97

0.00

1.1

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.0

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.3

—

(40757373) Influenza virus identified in Isolate

0.00

0.0

1.2

—

(3024471) HLA-A [Type]

0.00

0.0

1.0

—

(3027008) Opiates [Presence] in Urine

0.92

0.00

1.0

1.3

—

(3042733) HLA Ab [Presence] in Serum

0.00

0.0

4.4

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.92

0.00

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

0.92

0.00

1.0

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

18.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.94

0.00

2.3

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

1.0

—

129.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

0.0

2.0

—

10835.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(44806071)

0.00

0.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.99

0.00

1.1

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

2.2

—

123.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.0

3.4

—

57.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.97

0.00

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1.00

0.00

1.3

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.94

0.00

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

0.00

0.0

4.9

—

47.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

1.9

—

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_STENOEXTCAN and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_STENOEXTCAN	1.036 [0.77, 1.39]	0.814
Birth year	0.994 [0.99, 1.0]	0.2

During the follow-up period (1.1.1998 — 31.12.2019), 58 out of 489 females with H8_STENOEXTCAN died.

Males

Parameter	HR [95% CI]	p-value
H8_STENOEXTCAN	1.014 [0.79, 1.31]	0.914
Birth year	0.982 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 96 out of 868 males with H8_STENOEXTCAN died.

Mortality risk

Mortality risk for people of age

years, who have H8_STENOEXTCAN.

N-year risk	Females	Males
1	0.09%	0.156%
5	0.533%	1.027%
10	1.478%	2.479%
15	2.824%	4.708%
20	4.799%	7.887%

Relationships between endpoints

↥

Index endpoint: H8_STENOEXTCAN – Acquired stenosis of external ear canal

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Acquired stenosis of external ear canal

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints